Regulatory hub

Swissmedic: Overview of Medical Device Regulation in Switzerland

An overview of Swissmedic's role in market surveillance, oversight of conformity assessment bodies, and the legal framework for medical devices in Switzerland.

Overview

Summary of this regulator or jurisdiction and how it relates to market access.

Official regulator site

Role of Swissmedic in Medical Device Regulation

Swissmedic is the national authority responsible for the supervision of medical devices in Switzerland. Unlike medicinal products, medical devices do not undergo a government authorization process; instead, they rely on a conformity assessment system.

Key Responsibilities

Market Surveillance: Swissmedic monitors devices already on the market to ensure they remain safe and effective. This includes handling reports of incidents (Vigilance).
Designation of Notified Bodies: It designates and monitors private entities (Conformity Assessment Bodies) that evaluate whether devices meet regulatory standards.
Legal Framework Enforcement: It ensures compliance with the Medical Devices Ordinance (MedDO) and the Ordinance on In Vitro Diagnostic Medical Devices (IvDO).
Economic Operator Monitoring: It supervises manufacturers, importers, and the Swiss Authorized Representative (CH-REP) required for foreign manufacturers.
CE Marking Recognition: Switzerland recognizes the CE mark based on its alignment with EU regulations (MDR/IVDR), despite being a "third country" due to the non-update of the Mutual Recognition Agreement (MRA).

Regulatory Requirements

Devices must meet safety and performance requirements.
Foreign manufacturers must appoint a CH-REP to place products on the Swiss market.
Incident reporting (materiovigilance) is mandatory for manufacturers and healthcare professionals.

Articles & guides

Insight articles mapped to this region on ElendiLabs.

Post Market Surveillance

January 19, 2026

Incident and Field Safety Corrective Action Reporting Obligations for Medical Device Users and Operators in Switzerland

In Switzerland, users and operators of medical devices (healthcare professionals, institutions, importers) must report serious incidents, suspected trends, and field safety corrective actions to Swissmedic promptly under the MedDO vigilance system, ensuring patient safety through timely investigation, risk mitigation, and coordination with manufacturers.

Read article →

Other

January 17, 2026

Notification Procedure for Devitalised Human Tissue Products in Switzerland – Swissmedic Guidance

Swissmedic requires notification of devitalised human tissue products (allografts without viable cells) placed on the Swiss market, classifying them as medical devices under specific MedDO provisions, with mandatory submission of product details, donor screening, processing information, and conformity data to ensure safety, traceability, and regulatory oversight prior to distribution.

Read article →

Other

January 14, 2026

Frequently Asked Questions on the Swiss Medical Devices Database – Swissmedic Guidance

Swissmedic publishes a comprehensive FAQ section addressing common queries on registration, UDI, CHRN, data submission, updates, access rights, and compliance obligations for the medical devices database, assisting economic operators in meeting MedDO requirements efficiently.

Read article →

Other

January 13, 2026

Notification of Medical Devices Placed on the Swiss Market – Swissmedic Procedure

Swissmedic requires notification of all medical devices placed on the Swiss market via the mandatory registration in the Product Registration Database, replacing the former notification system with a comprehensive electronic process that includes device details, economic operator information, UDI where applicable, and vigilance data to support market surveillance and traceability under the revised MedDO.

Read article →

Other

January 13, 2026

Swissmedic Round Table on Medical Devices (RTMT) – Industry Dialogue Platform

Swissmedic's Round Table Medical Technology (RTMT) serves as a key stakeholder forum for regular exchange between the Swiss regulatory authority, industry representatives, and notified bodies to discuss current developments, implementation challenges, and future orientations in medical device regulation under the Swiss MedDO and EU MDR/IVDR alignment.

Read article →

Other

January 12, 2026

Vigilance Obligations for Reprocessed Medical Devices in Switzerland – Swissmedic Requirements

Swissmedic mandates that incidents involving reprocessed medical devices – whether reusable or exceptionally authorised single-use – must be reported promptly under MedDO vigilance rules, with specific emphasis on identifying reprocessing-related causes, enhanced documentation, and coordination between healthcare operators, reprocessors, and manufacturers to ensure effective risk mitigation and patient safety.

Read article →

Other

January 12, 2026

Notification of In Vitro Diagnostic Devices Placed on the Swiss Market – Swissmedic Requirements

Swissmedic mandates registration (serving as notification) of all in vitro diagnostic (IVD) medical devices placed on the Swiss market in the Product Registration Database, requiring submission of UDI data, economic operator details, conformity documentation, and classification information to enable traceability, vigilance, and regulatory oversight under the revised MedDO and IVDR-aligned framework.

Read article →

Post Market Surveillance

January 11, 2026

Vigilance Reporting Obligations for Medical Device Manufacturers and Importers in Switzerland

Manufacturers and importers in Switzerland must establish a vigilance system under MedDO to monitor incidents, report serious events and trends to Swissmedic within strict timelines, coordinate field safety corrective actions, maintain records, and ensure continuous risk management for placed medical devices.

Read article →

Clinical Trials

January 11, 2026

Performance Studies for In Vitro Diagnostic Medical Devices in Switzerland – Swissmedic Requirements

Swissmedic regulates performance studies for in vitro diagnostic (IVD) medical devices under the MedDO and ClinO-MD, requiring notification or authorisation depending on risk class, ethics committee approval, compliance with ISO 20916, informed consent, and rigorous safety monitoring to generate reliable performance data for conformity assessment and market placement.

Read article →

Other

January 11, 2026

Unique Device Identification (UDI) in Switzerland – Swissmedic Implementation

Swissmedic requires Unique Device Identification (UDI) for medical devices placed on the Swiss market to enable unambiguous identification, improve traceability, enhance post-market surveillance, and support patient safety in alignment with international standards and MedDO requirements.

Read article →

Other

January 10, 2026

Frequently Asked Questions by Patients on Medical Devices in Switzerland – Swissmedic Overview

Swissmedic provides answers to common patient questions about medical devices in Switzerland, covering topics such as device safety, how to identify approved products, what to do in case of problems, implants, recalls, and where to find reliable information, aiming to enhance patient understanding and safety under the MedDO regulatory framework.

Read article →

Other

January 10, 2026

Reprocessing of Single-Use and Reusable Medical Devices in Switzerland – Swissmedic Requirements

Swissmedic regulates the reprocessing of medical devices under MedDO, distinguishing between single-use devices (generally prohibited for reprocessing unless specifically authorised) and reusable devices (requiring validated cleaning, disinfection, sterilisation, and maintenance procedures by healthcare institutions or third-party providers to ensure safety and performance throughout the device's lifecycle).

Read article →

Import & Export

January 10, 2026

Swiss Export Certificates and Free Sale Certificates for Medical Devices

Swissmedic issues export certificates and free sale certificates for medical devices upon request to facilitate international trade, confirming regulatory status, conformity assessment, and market authorisation in Switzerland under MedDO requirements for manufacturers or authorised representatives.

Read article →

Other

January 10, 2026

Swiss Authorised Representative (CH-REP) for Medical Devices – Swissmedic Obligations

Non-Swiss manufacturers must appoint a Swiss Authorised Representative (CH-REP) to place medical devices on the Swiss market, ensuring regulatory compliance, vigilance reporting, technical documentation availability, and liaison with Swissmedic under the revised MedDO requirements.

Read article →

Clinical Trials

January 10, 2026

Clinical Investigations of Medical Devices in Switzerland – Swissmedic Regulatory Framework

Swissmedic regulates clinical investigations of medical devices in Switzerland under the MedDO and Human Research Act, requiring authorisation for higher-risk studies, adherence to good clinical practice, ethics committee approval, and strict safety and data protection standards to ensure participant protection and reliable evidence for market authorisation.

Read article →

Other

January 10, 2026

Swissmedic Medical Devices Database Playground – Test Environment

The Swissmedic Playground is a dedicated test environment within the medical devices database that allows economic operators to practice registration processes, validate data formats, simulate submissions, and familiarize themselves with the portal interface without affecting live production data.

Read article →

Other

January 10, 2026

Products without Intended Medical Purpose – Swissmedic Borderline Guidance

Swissmedic provides guidance on products that lack an intended medical purpose and are therefore not classified as medical devices under Swiss law, even if they may have similar form or function to regulated devices, helping manufacturers and distributors determine applicable regulatory requirements.

Read article →

Other

January 9, 2026

Swiss Single Registration Number (CHRN) for Medical Devices – Swissmedic Requirements

The Swiss Single Registration Number (CHRN) is a mandatory unique identifier assigned by Swissmedic to economic operators (manufacturers, authorised representatives, importers) involved in medical devices placed on the Swiss market, facilitating traceability, market surveillance, and compliance with the MedDO.

Read article →

Other

January 6, 2026

Product Registration Database for Medical Devices in Switzerland – Swissmedic Overview

Swissmedic maintains the Product Registration Database as a central register for medical devices placed on the Swiss market, requiring mandatory registration of devices, economic operators, and vigilance data to support traceability, market surveillance, and compliance with the MedDO.

Read article →

Clinical Trials

January 4, 2026

Combined Drug-Device Clinical Studies in Switzerland – Swissmedic Coordination Process

Swissmedic provides a coordinated procedure for clinical studies combining medicinal products and medical devices, requiring joint assessment by both medicinal products and medical devices divisions to address overlapping requirements under the Therapeutic Products Act, ensuring efficient authorisation, consistent evaluation of safety, efficacy, and performance data, and compliance with relevant ordinances.

Read article →